buthionine sulfoximine glutathione (BSO) decreases intracellular (GSH) resistant human breast cancer cells Sigma-Aldrich ʟ-Buthionine-sulfoximine, CAS 83730-53-4, ≥97%
Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg Proxidant Injection Causes the Onset of Type 2 Diabetes in the Spontaneously Hypertensive Obese (SHROB Kol) Rat Inquiries Journal L Buthionine (S,R) sulfoximine STEMCELL Technologies Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



